Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile?
Open Access
- 10 January 2011
- Vol. 117 (13), 2853-2862
- https://doi.org/10.1002/cncr.25842
Abstract
BACKGROUND: The objective of this study was to elicit future patients' preferences for preoperative chemoradiation (pre‐CRT) for rectal cancer to determine whether patients' preferences are consistent with current treatment guidelines. METHODS: During a standardized interview, the treatment protocol, risks, benefits, and long‐term outcomes associated with 1) surgery alone (SA) and 2) pre‐CRT followed by surgery (CR + S) were described to healthy individuals, and a threshold task was performed. Each participant was asked which treatment option they would prefer when the risk of local recurrence was set initially at 15% for both options. If the participant indicated SA (which was expected), then the risk of local recurrence for CR + S was lowered systematically until the participant's preference changed from SA to CR + S. This threshold point represented the risk of local recurrence for pre‐CRT that the participant would require before they would choose treatment with pre‐CRT. RESULTS: Fifty individuals participated in the study, and the majority were well educated. Twenty‐seven of 50 participants (54%) required a risk of local recurrence with CR + S of ≤5% (ie, equivalent to an absolute risk reduction ≥10%) before they would choose treatment with pre‐CRT. Regression analysis did not identify any variables that were predictive of the participants' preferences. CONCLUSIONS: Participants seemed to highly value functional outcomes and seemed willing to accept a higher risk of local recurrence to achieve this. Therefore, developers of future guidelines may need to downgrade the use of pre‐CRT for all patients with stage II/III tumors from a guideline to an option. Cancer 2011. © 2011 American Cancer Society.Keywords
This publication has 38 references indexed in Scilit:
- Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice GuidelineClinical Oncology, 2010
- Neoadjuvant Treatment of Rectal Carcinoma: Assessment of Health Care Services by Physicians and Lay PersonsJournal of Clinical Oncology, 2008
- Rectal Cancer at the Crossroads: The Dilemma of Clinically Staged T3, N0, M0 DiseaseJournal of Clinical Oncology, 2008
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006
- A decision aid to assist in adjuvant therapy choices for breast cancerPsycho‐Oncology, 2006
- Patient's Preferences for Adjuvant Postoperative Chemoradiation Therapy in Rectal CancerDiseases of the Colon & Rectum, 2005
- Prevalence of Male and Female Sexual Dysfunction Is High Following Surgery for Rectal CancerAnnals of Surgery, 2005
- Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk InformationMedical Decision Making, 2005
- The Stockholm II trial on preoperative radiotherapy in rectal carcinomaCancer, 2001
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992